Celluris is a start-up company with main objective to develop immunotherapy-based treatments for cancer. More specifically, Celluris is developing RefuaPepCAR, a Chimeric Antigen receptor T cell (CAR-T) based therapy for the treatment of different hematological and solid tumors.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Av Prof. Lineu Prestes, 2242, Bloco D Sala 265,brazil
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- celluris.com.br
- HQ
- São Paulo, SP
Celluris Questions
Celluris's website is celluris.com.br
Celluris's LinkedIn profile is https://br.linkedin.com/company/celluris
Celluris has
3 employees.
View email and phone details for 3
employees at Celluris.
Celluris's industry is
Biotechnology Research
Celluris's top competitors are
Biobreyer,
Gen-T,
Eva Scientific,
Imunotera,
Biolinker,
Bymycell - Genômica Simplificada,
Cellco Biotec,
Bioedtech,
Mirscience Therapeutics,
In Situ - Terapia Celular.
Celluris's categories are Biotechnology Research
Celluris's founding year is 2016
